{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:51:45Z","timestamp":1790268705747,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62004062"],"award-info":[{"award-number":["62004062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ22H120008"],"award-info":[{"award-number":["LQ22H120008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019542","name":"Basic Research Project of Wenzhou City","doi-asserted-by":"publisher","award":["Y2023140"],"award-info":[{"award-number":["Y2023140"]}],"id":[{"id":"10.13039\/501100019542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijbiomac.2024.137028","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T06:45:05Z","timestamp":1730443505000},"page":"137028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P1","title":["Lapatinib-loaded reductive-responsive hyaluronic acid-cholesterol nanoparticles for inhibiting metastasis of uveal melanoma"],"prefix":"10.1016","volume":"283","author":[{"given":"Zhihao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangcheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyun","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.137028_bb0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","article-title":"Advances in the clinical management of uveal melanoma","volume":"20","author":"Carvajal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101041","article-title":"Metastatic uveal melanoma: the final frontier","volume":"90","author":"Rantala","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835920965852","article-title":"Uveal melanoma: progress in molecular biology and therapeutics","volume":"12","author":"Li","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122458","article-title":"Ultrasound-enhanced nano catalyst with ferroptosis-apoptosis combined anticancer strategy for metastatic uveal melanoma","volume":"305","author":"Wang","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0030","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0035","article-title":"A novel stimuli-responsive injectable antibacterial hydrogel to achieve synergetic photothermal\/gene-targeted therapy towards uveal melanoma","volume":"8","author":"Wang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc.2016.25","article-title":"Targeting metastasis","volume":"16","author":"Steeg","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202207973","article-title":"Smart nanosystems for overcoming multiple biological barriers in cancer nanomedicines transport: design principles, progress, and challenges","volume":"19","author":"Lin","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biomaterials.2017.10.024","article-title":"Overcoming obstacles in the tumor microenvironment: recent advancements in nanoparticle delivery for cancer theranostics","volume":"156","author":"Overchuk","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nantod.2019.03.007","article-title":"Tumour microenvironment responsive nanoconstructs for cancer theranostic","volume":"26","author":"Gulzar","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41557-020-0426-3","article-title":"A programmable polymer library that enables the construction of stimuli-responsive nanocarriers containing logic gates","volume":"12","author":"Zhang","year":"2020","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202214025","article-title":"Histone deacetylase-triggered self-immolative peptide-cytotoxins for cancer-selective drug delivery","volume":"33","author":"Bai","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0070","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","article-title":"Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy","volume":"14","author":"Zhou","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0075","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1021\/acsnano.8b06104","article-title":"Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives","volume":"12","author":"El-Sawy","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002404","article-title":"Dose-dependent carbon-dot-induced ros promote uveal melanoma cell tumorigenicity via activation of mTOR signaling and glutamine metabolism","volume":"8","author":"Ding","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.addr.2018.10.012","article-title":"Physical stimuli-responsive vesicles in drug delivery: beyond liposomes and polymersomes","volume":"138","author":"Kauscher","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0090","doi-asserted-by":"crossref","first-page":"18273","DOI":"10.1021\/acsami.0c00355","article-title":"Reduction\/oxidation-responsive hierarchical nanoparticles with self-driven degradability for enhanced tumor penetration and precise chemotherapy","volume":"12","author":"Yin","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0095","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1021\/acsnano.7b03003","article-title":"Transformative nanomedicine of an amphiphilic camptothecin prodrug for long circulation and high tumor uptake in cancer therapy","volume":"11","author":"Zhang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0100","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1021\/ja401350x","article-title":"Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug","volume":"135","author":"Maiti","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0105","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1021\/acs.nanolett.8b00737","article-title":"Disulfide bond-driven oxidation- and reduction-responsive prodrug nanoassemblies for cancer therapy","volume":"18","author":"Sun","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2022.12.051","article-title":"Polysaccharide-based nanocarriers for efficient transvascular drug delivery","volume":"354","author":"Zhang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202204636","article-title":"Stabilizing RNA nanovaccines with transformable hyaluronan dynamic hydrogel for durable cancer immunotherapy","volume":"33","author":"Jia","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0120","first-page":"433","article-title":"Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer","volume":"6","author":"Liang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131789","article-title":"Natural polysaccharides and their derivatives targeting the tumor microenvironment: a review","volume":"268","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0130","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1039\/D1TB00628B","article-title":"Polysaccharide nanoparticles: from fabrication to applications","volume":"9","author":"Plucinski","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0135","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.3390\/cancers12102832","article-title":"Transcriptome profiling reveals new insights into the immune microenvironment and upregulation of novel biomarkers in metastatic uveal melanoma","volume":"12","author":"Krishna","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0140","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1167\/iovs.17-22272","article-title":"Phenotypic plasticity in uveal melanoma is not restricted to a tumor subpopulation and is unrelated to cancer stem cell characteristics","volume":"58","author":"Doherty","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201803549","article-title":"Hyaluronic acid-based activatable nanomaterials for stimuli-responsive imaging and therapeutics: beyond CD44-mediated drug delivery","volume":"31","author":"Choi","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2011.06.031","article-title":"Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response","volume":"156","author":"Mizrahy","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2018.04.015","article-title":"Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system","volume":"278","author":"Huang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0160","first-page":"2023","article-title":"Expression of epidermal growth factor receptor: risk factor in uveal melanoma","volume":"41","author":"Hurks","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0165","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1111\/febs.15869","article-title":"Development of new therapeutic options for the treatment of uveal melanoma","volume":"288","author":"Wang","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0170","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.ejca.2013.06.011","article-title":"Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by gefitinib and cetuximab triggered antibody-dependent cellular cytotoxicity","volume":"49","author":"Amaro","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0175","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/acs.biomac.8b01449","article-title":"Mitochondria targeting and destabilizing hyaluronic acid derivative-based nanoparticles for the delivery of lapatinib to triple-negative breast cancer","volume":"20","author":"Lee","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0180","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1021\/acs.jmedchem.1c01013","article-title":"Conjugates derived from lapatinib derivatives with cancer cell stemness inhibitors effectively reversed drug resistance in triple-negative breast cancer","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0185","first-page":"102","article-title":"Enzyme-triggered deep tumor penetration of a dual-drug nanomedicine enables an enhanced cancer combination therapy","volume":"26","author":"Gu","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0190","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jconrel.2020.10.023","article-title":"PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases","volume":"329","author":"Ni","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0195","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1200\/JCO.2005.12.157","article-title":"Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies","volume":"23","author":"Spector","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2018.12.047","article-title":"Heterotelechelic polymer prodrug nanoparticles: adaptability to different drug combinations and influence of the dual functionalization on the cytotoxicity","volume":"295","author":"Vinciguerra","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","article-title":"Advances in the clinical management of uveal melanoma","volume":"20","author":"Carvajal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0215","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41421-023-00521-7","article-title":"Nuclear PD-L1 promotes EGR1-mediated angiogenesis and accelerates tumorigenesis","volume":"9","author":"Yu","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0225","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1073\/pnas.131209798","article-title":"Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role invasculogenic mimicry","volume":"98","author":"Hendrix","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101684","article-title":"A cascade FRET photosensitizer that enhances photodynamic therapy for ocular melanoma","volume":"47","author":"Ruan","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0235","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1167\/iovs.19-27704","article-title":"Long noncoding RNA PVT1 silencing prevents the development of uveal melanoma by impairing microRNA-17-3p-dependent MDM2 upregulation","volume":"60","author":"Wu","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2024.137028_bb0240","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ymthe.2017.02.016","article-title":"CANT1 lncRNA triggers efficient therapeutic efficacy by correcting aberrant lncing cascade in malignant uveal melanoma","volume":"25","author":"Xing","year":"2017","journal-title":"Mol. Ther."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024078371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024078371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:16:24Z","timestamp":1782753384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024078371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"alternative-id":["S0141813024078371"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.137028","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lapatinib-loaded reductive-responsive hyaluronic acid-cholesterol nanoparticles for inhibiting metastasis of uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.137028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"137028"}}